PHF5A and hepatocellular carcinoma: Bioinformatics analyses and validation experiments suggested that PHF5A was upregulated and predicted an unfavorable prognosis in various cancers and was confirmed to be associated with malignant phenotypes, unfavorable outcome, angiogenesis, immune evasion and treatment efficacy in HCC with the study cohort.